2-(2-chloroethyl)-3,4-dihydro-1H-isoquinoline | 68085-34-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四氢异喹啉
• 英文名称: 2-(2-chloroethyl)-3,4-dihydro-1H-isoquinoline
• 英文别名: N-(2-Chlorethyl)-1,2,3,4-tetrahydroisochinolin；N-(2-Chlor-aethyl)-1,2,3,4-tetrahydroisochinolin；2-(2-chloroethyl)-1,2,3,4-tetrahydroisoquinoline
• CAS: 68085-34-7
• 化学式: C₁₁H₁₄ClN
• mdl: MFCD13188356
• 分子量: 195.692
• InChiKey: NKIMOCKFPDPYQI-UHFFFAOYSA-N

物化性质

• 沸点：
  103-105 °C(Press: 0.09 Torr)
• 密度：
  1?+-.0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-(2-chloroethyl)-3,4-dihydro-1H-isoquinoline 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 7.0h， 生成 N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-N-ethyl-4-oxo-4-(6-oxo-5H-pyrido[2,3-b][1,4]benzodiazepin-11-yl)butanamide
  参考文献：
  名称：

  合成具有5,11-二氢-6H-吡啶并[2,3-b] [1,4]苯并二氮杂-6-骨架作为有效和选择性的M2毒蕈碱受体拮抗剂的新型琥珀酰胺衍生物。一世。

  摘要：

  合成了一系列含有琥珀酰胺骨架的5,11-二氢-6H-吡啶并[2,3-b] [1,4]苯并二氮杂-1-酮衍生物，并评估了M1，M2和M3毒蕈碱受体的结合亲和力（体外）以及M2和M3毒蕈碱受体的拮抗活性（体内）。它们中的一些对M（2）毒蕈碱受体的结合亲和力比AF-DX 116更高。其中，11- [3- [N- [2-（N-苄基-N-甲基氨基）乙基] -N-乙基氨基甲酰基]丙酰基] -5,11-二氢-6H-吡咯[2,3-b] [1,4]苯并二氮杂-1--6（68）被发现是最有效和选择性的M2毒蕈碱受体体外拮抗剂。静脉内给药后，该化合物还强烈抑制氧代苯乙吗啡引起的心动过缓，并且在体内对M2毒蕈碱受体的选择性比M3毒蕈碱受体高130倍。

  DOI：

  10.1248/cpb.45.996
• 作为产物：
  描述：

  2-(3,4-二氢异喹啉-2(1H)-基)乙醇 在 氯化亚砜 作用下， 以 二氯甲烷 为溶剂， 生成 2-(2-chloroethyl)-3,4-dihydro-1H-isoquinoline
  参考文献：
  名称：

  [EN] HETEROCYCLIC COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN
  [FR] COMPOSÉS HÉTÉROCYCLIQUES ET AGENTS D'IMAGERIE POUR L'IMAGERIE DE LA PROTÉINE HUNTINGTINE

  摘要：

  本文提供了用于检测与蛋白聚集相关的疾病或病况，特别是与亨廷顿蛋白聚集相关的某些化合物和成像剂，以及它们的组合物和使用方法。

  公开号：

  WO2021252775A1

文献信息

• Autonomic Blocking Agents. II. Alkamine Esters and their Quaternaries
  作者：J. W. Cusic、Richard A. Robinson

  DOI：10.1021/jo50006a015

  日期：1951.12
• Synthesis of New Serotonin 5-HT₇ Receptor Ligands. Determinants of 5-HT₇/5-HT_1A Receptor Selectivity
  作者：Rocío A. Medina、Jessica Sallander、Bellinda Benhamú、Esther Porras、Mercedes Campillo、Leonardo Pardo、María L. López-Rodríguez

  DOI：10.1021/jm8014553

  日期：2009.4.23

  We report the synthesis of a new set of compounds of general structure I (1-20) with structural modifications in the pharmacophoric elements of the previously reported lead UCM-5600. The new derivatives have been evaluated for binding affinity at 5-HT7 and 5-HT1A receptors. The influence of the different structural features in terms of 5-HT7/5-HT1A receptor affinity and selectivity was analyzed by computational simulations of the complexes between compounds I and beta(2)-based 3-D models of these receptors. Compound 18 (HYD1 = 1,3-dihydro-2H-indol-2-one; spacer = -(CH2)(4)-; HYD2 + HYD3 = 3,4-dihydroisoquinolin-2(1H)-yl) exhibits high 5-HT7R affinity (K-i = 7 nM) and selectivity over the 5-HT1AR (31-fold), and has been characterized as a partial agonist of the human 5-HT7R.
• Plachta; Starosciak, Acta poloniae pharmaceutica, 1994, vol. 51, # 1, p. 51 - 54
  作者：Plachta、Starosciak

  DOI：——

  日期：——
• 2-[(3-Methoxyphenylethyl)phenoxy]-Based ABCB1 Inhibitors: Effect of Different Basic Side-Chains on Their Biological Properties
  作者：Nicola Antonio Colabufo、Francesco Berardi、Roberto Perrone、Simona Rapposelli、Maria Digiacomo、Michael Vanni、Aldo Balsamo

  DOI：10.1021/jm800928j

  日期：2008.12.11

  Recently, 2-[(3-methoxyphenylethyl)phenoxy]-moiety has been selected for the design and synthesis of new small ABCB1 inhibitors. In the present paper, this moiety has been linked through a spacer of 2-5 carbon atoms to the nitrogen of three different basic nuclei such as: (i) N-4-arylpiperazine, (ii) N-4-methylpiperazine, and (iii) 6,7-dimethoxytctrahydroisoquinoline. The results demonstrated that all the selected basic nuclei were well tolerated and that, globally, the best inhibitory activity for each series was obtained when the spacer between the 2-[(3-methoxyphenylethyl)phenoxy]moiety and the basic nucleus consisted of a four-carbon chain. Among the synthesized compounds, N-4-methylpiperazine- 10C (IC50 = 0.15 W) and tetrahydroisoquinoline-derivatives 11c (IC50 = 0.08 W) with the spacer n = 4 for both series, displayed the best potency to inhibit ABCB1 activity. Moreover, for each compound, the ABCB1 interacting mechanism has been evaluated by three combined biological assays. N-4-methylpiperazine- (10a-d) and tetrahydroisoquinoline-(11a-d) derivatives were Cyclosporin A-like ABCB1 nontransported substrates.
• Ethers of heterocyclic alcohols and tetrahydroisoquinolinealkanols, their salts and methods for their production
  申请人：SEARLE &

  公开号：US02785166A1

  公开（公告）日：1957-03-12